pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
LOFEXIDINE HYDROCHLORIDE
LOFEXIDINE HYDROCHLORIDE (LOFEXIDINE HYDROCHLORIDE)
Opium Withdrawal Syndrome
$BICXBioCorRx Inc.
1 catalysts
Marketed
fosfomycin disodium
Contepo (fosfomycin disodium [INN])
Pyelonephritis
Meitheal Pharmaceuticals Inc
1 catalysts
Marketed
Celebrex
Celecoxib Greenstone (celecoxib)
Osteoarthritis Pain
Greenstone LLC
11 catalysts
← prev
page 31 of 231
next →
131
Pain89
Neurology1
Marketed
DEFERASIROX
DEFERASIROX (DEFERASIROX)
Iron Poisoning
Reddy US Therapeutics Inc
7 catalysts
Marketed
spesolimab
Spevigo (spesolimab)
Pyoderma Gangrenosum
IL36 receptor
Boehringer Ingelheim International GmbH
5 catalysts
Marketed
STIMUFEND
STIMUFEND (PEGFILGRASTIM-FPGK)
Fresenius Kabi USA LLC
4 catalysts
Marketed
atrasentan hydrochloride
Vanrafia (atrasentan hydrochloride)
IgA Nephropathy (Berger's Disease)
$NVSNOVARTIS AG
2 catalysts
Marketed
PROPARACAINE HYDROCHLORIDE
PROPARACAINE HYDROCHLORIDE (PROPARACAINE HYDROCHLORIDE)
Local Anesthetic Effect
$ALCALCON INC
1 catalysts
Marketed
HADLIMA
HADLIMA (ADALIMUMAB-BWWD)
Samsung Bioepis Co Ltd
12 catalysts
Marketed
erdafitinib
Balversa (erdafitinib)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Fibroblast growth factor receptor
$JNJJOHNSON & JOHNSON
11 catalysts
Marketed
tacrolimus ER
Envarsus XR (tacrolimus)
Kidney Transplant Rejection
Veloxis Pharmaceuticals Inc
8 catalysts
Marketed
triamcinolone acetonide Rising
Triamcinolone Acetonide (triamcinolone acetonide)
Atopic Dermatitis (Atopic Eczema)
Rising Pharma Holdings Inc
6 catalysts
Marketed
BUSPIRONE HYDROCHLORIDE
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Anxiety Disorders
Zydus Pharmaceuticals USA Inc
5 catalysts
Marketed
tezepelumab
Tezspire (tezepelumab-ekko)
Eosinophilic Esophagitis
Thymic stromal lymphopoietin
$AMGNAMGEN INC
4 catalysts
Marketed
riboflavin 5'-phosphate sodium
Photrexa Viscous (riboflavin 5'-phosphate sodium)
Keratoconus
$GKOSGLAUKOS Corp
1 catalysts
Marketed
SEVOFLURANE
SEVOFLURANE (SEVOFLURANE)
General Anesthetic Effect
Piramal Critical Care Inc
18 catalysts
Marketed
YUFLYMA
YUFLYMA (ADALIMUMAB-AATY)
Celltrion Inc
14 catalysts
Marketed
AMJEVITA
AMJEVITA (ADALIMUMAB-ATTO)
Tumor necrosis factor
$AMGNAMGEN INC
13 catalysts
Marketed
HYRIMOZ
HYRIMOZ (ADALIMUMAB-ADAZ)
Sandoz Inc
13 catalysts
Marketed
CYLTEZO
CYLTEZO (ADALIMUMAB-ADBM)
Boehringer Ingelheim Corp
12 catalysts
Marketed
ganaxolone
Ztalmy (ganaxolone)
Seizures
Marinus Pharmaceuticals Inc
8 catalysts
Marketed
palopegteriparatide
Yorvipath (palopegteriparatide)
Hypoparathyroidism
Ascendis Pharma Inc
2 catalysts
Marketed
PANTOPRAZOLE SODIUM
PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)
Corrosive Esophagitis (Erosive Esophagitis)
Knack Pharmaceuticals Inc
14 catalysts
Marketed
fenfluramine hydrochloride
Fintepla (fenfluramine hydrochloride)
Unspecified Genetic Disorders
5-hydroxytryptamine receptor 2CSigma non-opioid intracellular receptor 1
UCB SA
11 catalysts
Marketed
LACOSAMIDE
LACOSAMIDE (LACOSAMIDE)
Generalized Seizures
UCB SA
6 catalysts
Marketed
futibatinib
Lytgobi (futibatinib)
Bile Duct Cancer (Cholangiocarcinoma)
Fibroblast growth factor receptor
Taiho Oncology Inc
3 catalysts
Marketed
upadacitinib tartrate ER
Rinvoq (upadacitinib tartrate)
Vitiligo
$ABBVAbbVie Inc.
19 catalysts
Marketed
opicapone
Ongentys (opicapone [INN])
Parkinson's Disease
$AMRXAmneal Pharmaceuticals, Inc.
3 catalysts
Marketed
upadacitinib
Rinvoq LQ (upadacitinib)
Polyarticular Juvenile Idiopathic Arthritis (PJIA)
$ABBVAbbVie Inc.
3 catalysts
Marketed
alirocumab
Praluent (alirocumab)
Heterozygous Familial Hypercholesterolemia (heFH)
Sanofi-Aventis US LLC
14 catalysts